Teva Pharmaceutical Industries Ltd. (NYSE,TASE:TEVA) has signed an agreement to sell its Sellersville, Pennsylvania facility to G&W Laboratories, Inc., salvaging 280 employees’ jobs and further streamlining its own operations by reducing excess manufacturing ...
Read More »Recent News
Byzantine Grape Seeds Discovered in the Negev
Scientists hope the discovery of 1,500-year-old grape seeds may help resurrect the Byzantine Empire’s world-renowned “Wine of the Negev” “The Wine of the Negev” was historically one of the finest and most ...
Read More »Evogene to Build Research Facility in the United States
Rehovot-based Evogene is establishing an R&D facility in St. Louis, Missouri. The central focus of the facility will be Evogene’s existing insect control program and it will be headed by Dr. James Presnail, ...
Read More »MediWound to Ring the NASDAQ Stock Market Closing Bell in Recognition of Burn Awareness Week
MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announced that Gal Cohen, MediWound’s Chief Executive Officer, will ring ...
Read More »Evogene Incorporates Gene Optimization Program into Collaboration with Monsanto
Evogene is incorporating its new gene optimization program into its long-term collaboration with Monsanto. The addition comes after Evogene identified and validated more than 1,000 genes that have entered Monsanto’s product pipeline which improve ...
Read More »Business
Teva Announces Sale of Pennsylvania Facility
Teva Pharmaceutical Industries Ltd. (NYSE,TASE:TEVA) has signed an agreement to sell its Sellersville, Pennsylvania facility to G&W Laboratories, Inc., salvaging 280 employees’ jobs and further streamlining its own operations by reducing excess manufacturing ...
Read More »Evogene to Build Research Facility in the United States
Rehovot-based Evogene is establishing an R&D facility in St. Louis, Missouri. The central focus of the facility will be Evogene’s existing insect control program and it will be headed by Dr. James Presnail, ...
Read More »MediWound to Ring the NASDAQ Stock Market Closing Bell in Recognition of Burn Awareness Week
MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announced that Gal Cohen, MediWound’s Chief Executive Officer, will ring ...
Read More »Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option
After its stock dropped over 80% last year with failed Phase III trial results, Alcobra has raised approximately $27.9 million in a public offering of ordinary shares. The full over allotment ...
Read More »Biotech/Pharma
-
Teva Announces Sale of Pennsylvania Facility
Teva Pharmaceutical Industries Ltd. (NYSE,TASE:TEVA) has signed an agreement to sell its Sellersville, Pennsylvania facility to G&W Laboratories, Inc., salvaging 280 employees’ jobs and further streamlining its own operations by reducing excess manufacturing ...
Read More » -
MediWound to Ring the NASDAQ Stock Market Closing Bell in Recognition of Burn Awareness Week
-
Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option
-
Therapix Biosciences and Dekel Pharmaceuticals Sign Binding Term Sheet Outlining Licensing and Royalty Agreement
Medical Devices
-
Syneron Medical Announces Preliminary Fourth Quarter 2014 Revenue
Total revenue in the range of $72 to $74 million, up 20% to 24% y/y (pro-forma excluding Syneron Beauty), including approximately 50% product revenue growth in North America Strong UltraShape ...
Read More » -
Doctors at Rambam Hospital Implant 3-D Printed Jaw in Wounded Syrian Man
-
Integrity Applications, Inc. Announces Completion Of Successful $8.5 Million Equity Financing
-
Mazor Robotics Reports Orders for Six Renaissance Systems During the Fourth Quarter of 2014